Back to All Events

Best of Hematology

Virtual Access Only | 3.75 CE/CME Credits & MOC Points

We invite you to join us for the 2nd Annual Best of Hematology Conference. This innovative and state of the art program will feature some of the world's leading hematologists to present the latest research and strategies for the care of hematological malignancies — incorporating data from the major oncologic annual meetings.

Program Chairs

Tapan Kadia, MD | M.D. Anderson Cancer Center

Betsy O’Donnell, MD | Dana-Farber Cancer Institute

 

Speakers

Roy F Chemaly, MD, MPH, FIDSA, FACP | University of Texas MD Anderson Cancer Center

Fredrick B. Hagemeister, MD | UTMD Anderson Cancer Center

Andrew Yee, MD | Massachusetts General Hospital

Naval Daver, MD | MD Anderson Cancer Center

William Dale, MD, PhD | City of Hope

Jorge Cortes, MD | Augusta University

Amin Alousi, MD | University of Texas, MD Anderson Cancer Center

Matthew Angelos, MD, PhD | University of Colorado Anschutz Medical Campus

Beth Faiman, PhD, MSN, APN-BC | Cleveland Clinic Taussing Cancer Institute

Nitin Jain, MD | MD Anderson Cancer Center

Naveen Pemmaraju, MD | MD Anderson Cancer Center

 

Conference Agenda
Saturday, February 1, 2025

8:00 AM
Coffee and Exhibits

8:30 AM
Welcome and Opening Remarks

8:35 AM
Advances in Leukemia: Targeted Treatments and Immunotherapy  Jorge Cortes, MD | Augusta University

8:50 AM
CAR-T Cell Therapy Innovations Nitin Jain, MD | MD Anderson Cancer Center

9:05 AM
Diagnostics: New Frontiers in Lymphoma Fredrick B. Hagemeister, MD| University of Texas, MD Anderson Cancer Center

9:20 AM
Gene Therapy in Hematologic Disorders Matthew Angelos, MD, PhD | University of Colorado Anschutz Medical Campus

9:35 AM
Breakfast and Exhibits

9:50 AM
Non-CME Presentation

10:35 AM
Updates in Diffuse Large B-cell Lymphoma (DLBL) Fredrick B. Hagemeister, MD | University of Texas, MD Anderson Cancer Center

10:50 AM
Advances in Chronic Lymphocytic Leukemia (CLL) Nitin Jain, MD | MD Anderson Cancer Center

11:05 AM
Break and Exhibits

11:30 AM
Multiple Myeloma: Emerging Therapies Andrew Yee, MD | Massachusetts General Hospital

11:45 AM
Updates in Myeloproliferative Neoplasms Naveen Pemmaraju, MD | MD Anderson Cancer Center

12:00 PM
Advances in Acute Myeloid Leukemia
Naval Daver, MD | MD Anderson Cancer Center

12:15 PM
Lunch and Exhibits

12:30 PM
Non-CME Presentation

1:15 PM
Hematopoietic Stem Cell Transplantation Updates Amin Alousi, MD | University of Texas, MD Anderson Cancer Center

1:30 PM
Patient Conversations: Navigating Complex Cases Beth Faiman, PhD, MSN, APN-BC | Cleveland Clinic Taussing Cancer Institute 

1:45 PM
Break and Exhibits

2:10 PM
Infection Management in Immunocompromised Patients Roy F Chemaly, MD, MPH, FIDSA, FACP | University of Texas MD Anderson Cancer Center

2:25 PM
Hematology and Aging: Tailoring Treatment for Older Adults William Dale, MD, PhD | City of Hope

2:40 PM
Addressing Health Disparities in Hematologic Oncology Beth Faiman, PhD, MSN, APN-BC | Cleveland Clinic Taussing Cancer Institute 

2:55 PM
Extended Panel Discussion: Integrating New Therapies into Practice Tapan Kadia, MD | MD Anderson Cancer Center Betsy O'Donnell, MD | Dana-Farber Cancer Institute Nitin Jain, MD | MD Anderson Cancer Center. Jorge Cortes, MD | Augusta University Roy F Chemaly, MD, MPH, FIDSA, FACP | University of Texas MD Anderson Cancer Center William Dale, MD, PhD | City of Hope Beth Faiman, PhD, MSN, APN-BC | Cleveland Clinic Taussing Cancer Institute  Naveen Pemmaraju, MD | MD Anderson Cancer Center Amin Alousi, MD | MD Anderson Cancer Center Naval Daver, MDMD Anderson Cancer Center Matthew Angelos, MD, PhD | University of Colorado Anschutz Medical Campus

3:40 PM
Adjourn

Agenda Subject To Change. All times are MST.

 
    • Apply the current standards of oncology care and key updates from national clinical guidance pathways to optimize the management of patients with various hematologic malignancies.

    • Review new, emerging, and novel therapeutic agents and treatment strategies and incorporate these into the management of patients with hematologic malignancies.

    • Communicate with members of the interprofessional oncology care team to improve collaborative performance in the management of patients with hematologic malignancies.

  • In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Nurses (ANCC) Credit Designation

    Amedco LLC designates this activity for a maximum of 3.75 ANCC contact hours.

    Physicians (ACCME) Credit Designation

    Amedco LLC designates this live activity for a maximum of 3.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Pharmacists and Pharmacy Technicians (ACPE) Credit Designation

    Amedco LLC designates this activity for a maximum of 3.75 knowledge-based CPE contact hours.

    NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.

    American Board of Internal Medicine (ABIM) MOC Credit

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.75 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.

    • Free registration for all healthcare providers

    • Expert sessions that present the most clinically relevant data, research, and clinical strategies

    • Real-time discussion and debate

    • Networking with peers, colleagues, and medical professionals

    • Access to the latest industry information and resources

 
Previous
Previous
November 16

Multidisciplinary Head and Neck Cancer Symposium

Next
Next
February 6

Cancer Updates GI and Breast